万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>医学(研究与实验)
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学

DRUG DELIVERY AND TRANSLATIONAL RESEARCH《药物输送和转化研究》 (官网投稿)

简介
  • 期刊简称DRUG DELIV TRANSL RE
  • 参考译名《药物输送和转化研究》
  • 核心类别 SCIE(2024版), 目次收录(维普), 目次收录(知网),外文期刊,
  • IF影响因子
  • 自引率4.70%
  • 主要研究方向医学-MEDICINE, RESEARCH & EXPERIMENTAL医学:研究与实验;PHARMACOLOGY & PHARMACY药学

主要研究方向:

等待设置主要研究方向
医学-MEDICINE, RESEARCH & EXPERIMENTAL医学:研究与实验;PHARMACOLOGY & PHARMACY药学

DRUG DELIVERY AND TRANSLATIONAL RESEARCH《药物输送和转化研究》(双月刊). Drug Delivery and Translational Research publishes research focused on such topics ...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://www.springer.com/journal/13346/

3、投稿网址:https://www.editorialmanager.com/DDTR

4、官网邮箱:相关咨询邮箱如下。

5、期刊刊期:双月刊,逢双月出版。

2021年1023日星期六

                          

 

期刊相关咨询邮箱【官网信息】

 

Contact the journal

Submission-related enquiries

Queries about submission issues, peer review process, or the status of your manuscript should be sent to Jaybert Arellado (jaybert.arellado@springernature.com).

Production-related enquiries

Queries about accepted manuscripts in production or post-publication corrections should be sent to Jodi Borgenicht (jodi.borgenicht@springer.com).

Rights and Permissions enquiries

For permission requests to reuse or reprint content, please follow the link ‘Rights and permissions’ on the relevant article page. For other queries, contact journalpermissions@springernature.com.

Publication-related enquiries

Queries related to journal publishing should be sent to Michael Baden-Campbell (michael.baden-campbell@springernature.com).

 

投稿须知【官网信息】

 

Drug Delivery and Translational Research

Submission guidelines

Instructions for Authors

Manuscript Submission

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions

Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission

Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.

Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.

Cover Letter

Providing a cover letter can help you convey the work's importance to the editors and to explain why you consider it appropriate for publication in Drug Delivery and Translational Research. If your manuscript has been solicited by a member of the Editorial board, the nature of that invitation should be detailed. The cover letter is not transmitted to peer reviewers. In the cover letter, the authors must disclose the significance of the work presented in the manuscript and details of any related manuscripts that are under consideration or in press elsewhere. The authors are invited to propose up to six (6) reviewers who would be qualified to review the manuscript, with their affiliation and institutional email address. Please note, the gmail addresses will not be considered. The authors are also encouraged to disclose any peer-reviewers who should be excluded from the process (with explanation why).

Publication Fees

There are no fees to submit or publish unless an author chooses to publish an article with color figures in print or if an author chooses to publish Open Access.

Title Page

Please make sure your title page contains the following information.

Title

The title should be concise and informative.

Author information

The name(s) of the author(s)

The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country

A clear indication and an active e-mail address of the corresponding author

If available, the 16-digit ORCID of the author(s)

If address information is provided with the affiliation(s) it will also be published.

For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.

Abstract

Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.

For life science journals only (when applicable)

Trial registration number and date of registration for prospectively registered trials

Trial registration number and date of registration, followed by “retrospectively registered”, for retrospectively registered trials

Keywords

Please provide 4 to 6 keywords which can be used for indexing purposes.

Statements and Declarations

The following statements should be included under the heading "Statements and Declarations" for inclusion in the published paper. Please note that submissions that do not include relevant declarations will be returned as incomplete.

Competing Interests: Authors are required to disclose financial or non-financial interests that are directly or indirectly related to the work submitted for publication. Please refer to “Competing Interests and Funding” below for more information on how to complete this section.

Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.

……

更多详情:

https://www.springer.com/journal/13346/submission-guidelines


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭